FAScinate Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 3

FAScinate Therapeutics General Information

Description

Developer of novel drugs and therapeutics designed to treat Parkinson's disease. The company develops drugs for neurodegenerative diseases such as multiple system atrophy, enabling the healthcare industry to help patients modify the disease course and improve patients' overall quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4365 Executive Drive
  • Suite 660
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4365 Executive Drive
  • Suite 660
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FAScinate Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC Cancelled Clinical Trials - Phase 2
2. Early Stage VC (Series A) 01-Aug-2020 Completed Clinical Trials - Phase 2
1. Accelerator/Incubator Completed Clinical Trials - Phase 2
To view FAScinate Therapeutics’s complete valuation and funding history, request access »

FAScinate Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view FAScinate Therapeutics’s complete cap table history, request access »

FAScinate Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FAScinate Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kainos Medicine Corporation Minority
Wells Investment Growth/Expansion Minority
CONNECT (San Diego) Accelerator/Incubator
To view FAScinate Therapeutics’s complete investors history, request access »

FAScinate Therapeutics Investments (1)

FAScinate Therapeutics’s most recent deal was a Seed Round with Egret Therapeutics. The deal was made on 15-Feb-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Egret Therapeutics 15-Feb-2022 Seed Round Biotechnology
To view FAScinate Therapeutics’s complete investments history, request access »

FAScinate Therapeutics FAQs

  • When was FAScinate Therapeutics founded?

    FAScinate Therapeutics was founded in 2018.

  • Where is FAScinate Therapeutics headquartered?

    FAScinate Therapeutics is headquartered in San Diego, CA.

  • What is the size of FAScinate Therapeutics?

    FAScinate Therapeutics has 3 total employees.

  • What industry is FAScinate Therapeutics in?

    FAScinate Therapeutics’s primary industry is Drug Discovery.

  • Is FAScinate Therapeutics a private or public company?

    FAScinate Therapeutics is a Private company.

  • What is FAScinate Therapeutics’s current revenue?

    The current revenue for FAScinate Therapeutics is .

  • How much funding has FAScinate Therapeutics raised over time?

    FAScinate Therapeutics has raised $15M.

  • Who are FAScinate Therapeutics’s investors?

    Kainos Medicine, Wells Investment, and CONNECT (San Diego) have invested in FAScinate Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process